The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach
- PMID: 3899154
- PMCID: PMC1977206
- DOI: 10.1038/bjc.1985.193
The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach
Abstract
Most drugs available for cancer chemotherapy exert their effects through cytodestruction. Although significant advances have been attained with these cytotoxic agents in several malignant diseases, response is often accompanied by significant morbidity and many common malignant tumours respond poorly to existing cytotoxic therapy. Development of chemotherapeutic agents with non-cytodestructive actions appears desirable. Considerable evidence exists which indicates that (a) the malignant state is not irreversible and represents a disease of altered maturation, and (b) some experimental tumour systems can be induced by chemical agents to differentiate to mature end-stage cells with no proliferative potential. Thus, it is conceivable that therapeutic agents can be developed which convert cancer cells to benign forms. To study the phenomenon of blocked maturation, squamous carcinoma SqCC/Y1 cells were employed in culture. Using this system it was possible to demonstrate that physiological levels of retinoic acid and epidermal growth factor were capable of preventing the differentiation of these malignant keratinocytes into a mature tissue-like structure. The terminal differentiation caused by certain antineoplastic agents was investigated in HL-60 promyelocytic leukaemia cells to provide information on the mechanism by which chemotherapeutic agents induce cells to by-pass a maturation block. The anthracyclines aclacinomycin A and marcellomycin were potent inhibitors of N-glycosidically linked glycoprotein biosynthesis and transferrin receptor activity, and active inducers of maturation; temporal studies suggested that the biochemical effects were associated with the differentiation process. 6-Thioguanine produced cytotoxicity in parental cells by forming analog nucleotide. In hypoxanthine-guanine phosphoribosyltransferase negative HL-60 cells the 6-thiopurine initiated maturation; this action was due to the free base (and possibly the deoxyribonucleoside), a finding which separated termination of proliferation due to cytotoxicity from that caused by maturation.
Similar articles
-
Mechanisms involved in the induction of malignant cell differentiation.Adv Enzyme Regul. 1986;25:507-29. doi: 10.1016/0065-2571(86)90031-2. Adv Enzyme Regul. 1986. PMID: 3544708 Review.
-
Induction of leukemia cell differentiation by chemotherapeutic agents.Adv Enzyme Regul. 1983;21:3-20. doi: 10.1016/0065-2571(83)90005-5. Adv Enzyme Regul. 1983. PMID: 6400065 Review.
-
Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.Cancer Res. 1982 Jul;42(7):2651-5. Cancer Res. 1982. PMID: 6952957
-
Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.Cancer Res. 1988 Jan 1;48(1):52-8. Cancer Res. 1988. PMID: 2825968
-
Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.Cancer Res. 1984 Jul;44(7):2807-12. Cancer Res. 1984. PMID: 6327026
Cited by
-
Methylated oxypurines and induction of differentiation of murine erythroleukemia cells.Mol Cell Biochem. 1990 Jan 18;92(1):37-44. doi: 10.1007/BF00220717. Mol Cell Biochem. 1990. PMID: 2106620
-
Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).Br J Cancer. 1989 Oct;60(4):578-84. doi: 10.1038/bjc.1989.317. Br J Cancer. 1989. PMID: 2803927 Free PMC article.
-
Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamine.Br J Cancer. 1987 Aug;56(2):127-32. doi: 10.1038/bjc.1987.169. Br J Cancer. 1987. PMID: 2444242 Free PMC article.
-
Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.Bioorg Med Chem. 2008 Mar 15;16(6):3352-60. doi: 10.1016/j.bmc.2007.12.007. Epub 2007 Dec 8. Bioorg Med Chem. 2008. PMID: 18166465 Free PMC article.
-
Amniotic membrane promotes doxorubicin potency by suppressing SH-SY5Y neuroblastoma cell angiogenesis.BMC Cancer. 2025 Jun 19;25(1):1021. doi: 10.1186/s12885-025-14442-z. BMC Cancer. 2025. PMID: 40537738 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials